OrbiMed’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-250,000
Closed -$2.08M – 146
2015
Q2
$2.08M Buy
+250,000
New +$1.21M 0.02% 127

Other funds holding SGYP

OrbiMed's SGYP Position: Q4 2017 in Review

OrbiMed sold out of Synergy Pharmaceuticals (SGYP) in Q4 2017, closing a stake of 13,621,443 shares — an estimated $39.5M sold.

OrbiMed first reported a position in SGYP in Q1 2015 and held it in 11 quarters. The position peaked at $111M in Q4 2016. 150 funds tracked by Wall St. Rank hold SGYP as of Q4 2017.

  • OrbiMed reported no remaining Synergy Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • OrbiMed sold 13,621,443 Synergy Pharmaceuticals shares in Q4 2017, an estimated $39.5M.
  • OrbiMed first reported a position in Synergy Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • OrbiMed's Synergy Pharmaceuticals position peaked at $111M in Q4 2016.
  • 150 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q4 2017.

Based on OrbiMed's 13F filing for Q4 2017, filed 14 Feb 2018.